Supaporn Roymanee^1,*, Nantawan Su-angka^1,2, Worakan Promphan^2,3,*, Kanjarut Wongwaitaweewong¹, Jirayut Jarutach¹, Rujira Buntharikpornpun¹, Pimpak Prachasilchai^2,3

Congenital Heart Disease, Vol.18, No.2, pp. 169-181, 2023, DOI:10.32604/chd.2023.021238 - 15 March 2023

Abstract Background: Ventricular septal defect (VSD) is the most common congenital heart disease. Transcatheter VSD closure is an effective treatment for patients with muscular and perimembranous VSD. However, there is a limit data for outlet VSD, especially impact to the aortic valve leaflet after transcatheter closure. This study aims to assess the outcomes of transcatheter closure of the outlet-type ventricular septal defect (OVSD) after 1 postoperative year. Methods: A retrospective study was performed including 50 patients who underwent transcatheter (n = 25) and surgical (n = 25) OVSD closure during the exact time frame at two medical centres. Results: The median age… More > Graphic Abstract

Wenqian Zhang^1,2,#, Chaojie Wang^1,3,#, Lingmei Zhou^2,4,#, Junjie Li², Jijun Shi², Yumei Xie², Mingyang Qian², Shushui Wang², Zhiwei Zhang^1,2,*

Congenital Heart Disease, Vol.16, No.5, pp. 519-528, 2021, DOI:10.32604/CHD.2021.015527 - 03 June 2021

Abstract Objective: This study aims to evaluate the morphology and function of the aortic valve after transcatheter closure of ventricular septal defect (VSD) with aortic valve prolapse (AVP) abased on clinical and radiological outcomes. Methods: From January 2013 to November 2014, 164 consecutive patients (97 males, 59.1%) with VSD and AVP were treated by transcatheter closure. The patients were divided into the mild AVP group (n = 63), moderate AVP group (n = 89) and severe AVP group (n = 12). The clinical and radiological outcomes of these patients were analyzed retrospectively. Results: In total, 146 (89.0%) patients… More >

Alexander C. Egbe^*, Heidi M. Connolly^*, Joseph T. Poterucha^*,†, Carole A. Warnes^*

Congenital Heart Disease, Vol.12, No.1, pp. 24-31, 2017

Abstract Objectives. There is a paucity of data about mixed aortic valve disease (MAVD) in patients with bicuspid/unicuspid aortic valve (BAV). This study sought to describe the outcomes of patients with moderate/severe MAVD.
Methods. We queried our database for patients with BAV and moderate/severe MAVD seen between 1994 and 2013. We excluded patients with baseline New York Heart Association (NYHA) III/IV symptoms, left ventricular ejection fraction <50%, aortic dimension >50 mm, and significant disease of other valves. The purpose of the study was to determine the freedom from NYHA III/IV symptoms and aortic valve replacement (AVR).
Results. We identified… More >